Research Article
Attenuation and Immunogenicity of a Live High Pathogenic PRRSV Vaccine Candidate with a 32-Amino Acid Deletion in the nsp2 Protein
Table 3
Nine unique amino acids positions that varied in PRRSV attenuation process.
| VR-2332/RespPRRSV-MLV | JXA1/JXA1R | HuN4/HuN4-F112 | TJ/TJM | QY1/QY100 |
| GP2 (L10/F10) | GP2 (L10/F10) | | | GP2 (L10/F10)* | | GP2 (Y50/F50) | GP2 (Y50/S50) | | GP2 (Y50/F50) | | | GP2 (I118/V118) | | GP2 (I118/V118) | E (D9/Y9) | E (D9/N9) | E (D9/N9) | | E (D9/N9) | | E (L48/F48) | E (L48/F48) | | E (L48/F48) | | GP3 (H79/N79) | | GP3 (F143/L143) | GP3 (H79/N79) | | GP4 (D43/G43) | GP4 (D43/N43) | GP4 (D43/G43) | GP4 (D43/N43) | | | | GP5 (G80/V80) | GP5 (G80/V80) | | | GP5 (Q196/R196) | GP5 (Q196/R196) | GP5 (Q196/R196) |
|
|
Synonymous mutation.
|